Announcements Trials
Browse Landscape

Phase

Phase 4 11Phase 3 7Phase 2 7Phase NA 3Phase 2/3 3Phase 1/2 2Phase 1 2

Status

Withdrawn 2Recruiting 2Completed 2Not yet recruiting 1

Sponsor Class

OTHER 7

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 4Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Genitourinary 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1PDAC - Pancreatic Ductal Adenocarcinoma 1Leukemia, B-Cell 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1Anastomotic Leak 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 2 × Interventional × Ciprofloxacin × Clear all
NCT06728072 2026-05-06

Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer

Virginia Commonwealth University

Phase 2 Recruiting
97 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07028424 2025-07-01

PANORAMIX

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Not yet recruiting
206 enrolled
Gastrointestinal

PDAC - Pancreatic Ductal Adenocarcinoma

NCT05462496 2024-10-15

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Icahn School of Medicine at Mount Sinai

Phase 2 Recruiting
25 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn
Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

NCT01279252 2019-01-25

CLEAR

King's College Hospital NHS Trust

Phase 2 Completed
71 enrolled
LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT02252978 2018-07-05

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy

Wake Forest University Health Sciences

Phase 2 Withdrawn
Genitourinary

Prostatic Neoplasms

NCT00139230 2008-06-03

Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Dana-Farber Cancer Institute

Phase 2 Completed
30 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡